HEADER LIPID BINDING PROTEIN 08-JUN-16 5L8O TITLE CRYSTAL STRUCTURE OF HUMAN FABP6 IN COMPLEX WITH CHOLATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GASTROTROPIN; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: GT,FATTY ACID-BINDING PROTEIN 6,ILEAL LIPID-BINDING PROTEIN, COMPND 5 ILBP,INTESTINAL 15 KDA PROTEIN,I-15P,INTESTINAL BILE ACID-BINDING COMPND 6 PROTEIN,I-BABP; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FABP6, ILBP, ILLBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FABP6, FATTY ACID BINDING PROTEIN 6, ILEAL BILE ACID BINDING PROTEIN, KEYWDS 2 I-BABP, ILEAL, GASTROTROPIN, FRAGMENTS, CHOLATE, LIPID BINDING KEYWDS 3 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.HENDRICK,I.MUELLER,P.M.LEONARD,R.DAVENPORT,P.MITCHELL REVDAT 3 21-SEP-16 5L8O 1 JRNL REVDAT 2 31-AUG-16 5L8O 1 JRNL REVDAT 1 24-AUG-16 5L8O 0 JRNL AUTH A.G.HENDRICK,I.MULLER,H.WILLEMS,P.M.LEONARD,S.IRVING, JRNL AUTH 2 R.DAVENPORT,T.ITO,J.REEVES,S.WRIGHT,V.ALLEN,S.WILKINSON, JRNL AUTH 3 H.HEFFRON,R.BAZIN,J.TURNEY,P.J.MITCHELL JRNL TITL IDENTIFICATION AND INVESTIGATION OF NOVEL BINDING FRAGMENTS JRNL TITL 2 IN THE FATTY ACID BINDING PROTEIN 6 (FABP6). JRNL REF J.MED.CHEM. V. 59 8094 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27500412 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00869 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0131 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 13374 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 731 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.45 REMARK 3 REFLECTION IN BIN (WORKING SET) : 985 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 53 REMARK 3 BIN FREE R VALUE : 0.3020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2783 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 45 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.28000 REMARK 3 B22 (A**2) : -1.02000 REMARK 3 B33 (A**2) : 1.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.50000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.679 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.318 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.272 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.710 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2874 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2606 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3886 ; 1.135 ; 1.939 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5957 ; 0.809 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 368 ; 6.158 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 123 ;37.528 ;24.878 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 450 ;13.423 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;13.497 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 448 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3299 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 678 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1484 ; 1.751 ; 5.467 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1483 ; 1.751 ; 5.467 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1848 ; 3.120 ; 8.200 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1849 ; 3.119 ; 8.200 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1390 ; 1.520 ; 5.530 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1390 ; 1.520 ; 5.530 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2039 ; 2.649 ; 8.233 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2846 ; 4.739 ;42.373 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2847 ; 4.739 ;42.379 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5L8O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1200000333. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14115 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 59.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.75400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3ELX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 41% W/V PEG 3350 AND 0.1 M BIS-TRIS PH REMARK 280 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.36000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 55 REMARK 465 GLY A 56 REMARK 465 GLY A 57 REMARK 465 ALA A 128 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ALA B 128 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 ALA C 128 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 13 CG CD CE NZ REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 GLU A 30 CG CD OE1 OE2 REMARK 470 LYS A 31 CG CD CE NZ REMARK 470 HIS A 58 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 68 CG CD CE NZ REMARK 470 ASN A 71 CG OD1 ND2 REMARK 470 ILE A 72 CG1 CG2 CD1 REMARK 470 LYS A 78 CG CD CE NZ REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 LYS A 125 CG CD CE NZ REMARK 470 GLU B 17 CG CD OE1 OE2 REMARK 470 ASP B 27 CG OD1 OD2 REMARK 470 GLU B 30 CG CD OE1 OE2 REMARK 470 LYS B 31 CG CD CE NZ REMARK 470 LYS B 36 CG CD CE NZ REMARK 470 GLU B 40 CG CD OE1 OE2 REMARK 470 LYS B 68 CG CD CE NZ REMARK 470 GLU B 69 CG CD OE1 OE2 REMARK 470 GLN B 73 CG CD OE1 NE2 REMARK 470 LYS B 81 CG CD CE NZ REMARK 470 ASN B 94 CG OD1 ND2 REMARK 470 ASP B 107 CG OD1 OD2 REMARK 470 LYS B 125 CG CD CE NZ REMARK 470 LYS C 13 CG CD CE NZ REMARK 470 ASP C 16 CG OD1 OD2 REMARK 470 GLU C 17 CG CD OE1 OE2 REMARK 470 LYS C 20 CG CD CE NZ REMARK 470 LEU C 22 CG CD1 CD2 REMARK 470 LYS C 31 CG CD CE NZ REMARK 470 PHE C 35 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS C 36 CG CD CE NZ REMARK 470 SER C 55 OG REMARK 470 LYS C 68 CG CD CE NZ REMARK 470 GLU C 69 CG CD OE1 OE2 REMARK 470 GLN C 73 CG CD OE1 NE2 REMARK 470 LYS C 78 CG CD CE NZ REMARK 470 LYS C 81 CG CD CE NZ REMARK 470 ASN C 94 CG OD1 ND2 REMARK 470 GLU C 103 CG CD OE1 OE2 REMARK 470 ASP C 107 CG OD1 OD2 REMARK 470 LYS C 108 CG CD CE NZ REMARK 470 ILE C 115 CG1 CG2 CD1 REMARK 470 TYR C 120 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS C 125 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 96 101.62 -39.33 REMARK 500 ASP B 44 77.20 -116.01 REMARK 500 SER B 55 -146.82 53.63 REMARK 500 SER C 55 -71.64 65.04 REMARK 500 ASN C 97 -1.08 87.26 REMARK 500 ILE C 115 62.64 -112.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR B 54 SER B 55 146.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CHD B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG B 1002 DBREF 5L8O A 1 128 UNP P51161 FABP6_HUMAN 1 128 DBREF 5L8O B 1 128 UNP P51161 FABP6_HUMAN 1 128 DBREF 5L8O C 1 128 UNP P51161 FABP6_HUMAN 1 128 SEQRES 1 A 128 MET ALA PHE THR GLY LYS PHE GLU MET GLU SER GLU LYS SEQRES 2 A 128 ASN TYR ASP GLU PHE MET LYS LEU LEU GLY ILE SER SER SEQRES 3 A 128 ASP VAL ILE GLU LYS ALA ARG ASN PHE LYS ILE VAL THR SEQRES 4 A 128 GLU VAL GLN GLN ASP GLY GLN ASP PHE THR TRP SER GLN SEQRES 5 A 128 HIS TYR SER GLY GLY HIS THR MET THR ASN LYS PHE THR SEQRES 6 A 128 VAL GLY LYS GLU SER ASN ILE GLN THR MET GLY GLY LYS SEQRES 7 A 128 THR PHE LYS ALA THR VAL GLN MET GLU GLY GLY LYS LEU SEQRES 8 A 128 VAL VAL ASN PHE PRO ASN TYR HIS GLN THR SER GLU ILE SEQRES 9 A 128 VAL GLY ASP LYS LEU VAL GLU VAL SER THR ILE GLY GLY SEQRES 10 A 128 VAL THR TYR GLU ARG VAL SER LYS ARG LEU ALA SEQRES 1 B 128 MET ALA PHE THR GLY LYS PHE GLU MET GLU SER GLU LYS SEQRES 2 B 128 ASN TYR ASP GLU PHE MET LYS LEU LEU GLY ILE SER SER SEQRES 3 B 128 ASP VAL ILE GLU LYS ALA ARG ASN PHE LYS ILE VAL THR SEQRES 4 B 128 GLU VAL GLN GLN ASP GLY GLN ASP PHE THR TRP SER GLN SEQRES 5 B 128 HIS TYR SER GLY GLY HIS THR MET THR ASN LYS PHE THR SEQRES 6 B 128 VAL GLY LYS GLU SER ASN ILE GLN THR MET GLY GLY LYS SEQRES 7 B 128 THR PHE LYS ALA THR VAL GLN MET GLU GLY GLY LYS LEU SEQRES 8 B 128 VAL VAL ASN PHE PRO ASN TYR HIS GLN THR SER GLU ILE SEQRES 9 B 128 VAL GLY ASP LYS LEU VAL GLU VAL SER THR ILE GLY GLY SEQRES 10 B 128 VAL THR TYR GLU ARG VAL SER LYS ARG LEU ALA SEQRES 1 C 128 MET ALA PHE THR GLY LYS PHE GLU MET GLU SER GLU LYS SEQRES 2 C 128 ASN TYR ASP GLU PHE MET LYS LEU LEU GLY ILE SER SER SEQRES 3 C 128 ASP VAL ILE GLU LYS ALA ARG ASN PHE LYS ILE VAL THR SEQRES 4 C 128 GLU VAL GLN GLN ASP GLY GLN ASP PHE THR TRP SER GLN SEQRES 5 C 128 HIS TYR SER GLY GLY HIS THR MET THR ASN LYS PHE THR SEQRES 6 C 128 VAL GLY LYS GLU SER ASN ILE GLN THR MET GLY GLY LYS SEQRES 7 C 128 THR PHE LYS ALA THR VAL GLN MET GLU GLY GLY LYS LEU SEQRES 8 C 128 VAL VAL ASN PHE PRO ASN TYR HIS GLN THR SER GLU ILE SEQRES 9 C 128 VAL GLY ASP LYS LEU VAL GLU VAL SER THR ILE GLY GLY SEQRES 10 C 128 VAL THR TYR GLU ARG VAL SER LYS ARG LEU ALA HET PEG A2001 7 HET CHD B1001 29 HET PEG B1002 7 HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM CHD CHOLIC ACID FORMUL 4 PEG 2(C4 H10 O3) FORMUL 5 CHD C24 H40 O5 FORMUL 7 HOH *45(H2 O) HELIX 1 AA1 ASN A 14 GLY A 23 1 10 HELIX 2 AA2 SER A 25 ARG A 33 1 9 HELIX 3 AA3 ASN B 14 LEU B 22 1 9 HELIX 4 AA4 SER B 25 ASN B 34 1 10 HELIX 5 AA5 ASN C 14 GLY C 23 1 10 HELIX 6 AA6 SER C 25 ARG C 33 1 9 SHEET 1 AA1 9 MET A 60 THR A 65 0 SHEET 2 AA1 9 ASP A 47 HIS A 53 -1 N PHE A 48 O PHE A 64 SHEET 3 AA1 9 VAL A 38 ASP A 44 -1 N GLU A 40 O SER A 51 SHEET 4 AA1 9 GLY A 5 LYS A 13 -1 N PHE A 7 O THR A 39 SHEET 5 AA1 9 VAL A 118 ARG A 126 -1 O VAL A 123 N SER A 11 SHEET 6 AA1 9 LYS A 108 ILE A 115 -1 N SER A 113 O TYR A 120 SHEET 7 AA1 9 TYR A 98 ILE A 104 -1 N GLU A 103 O VAL A 110 SHEET 8 AA1 9 LYS A 90 PHE A 95 -1 N PHE A 95 O TYR A 98 SHEET 9 AA1 9 GLN A 85 GLU A 87 -1 N GLN A 85 O VAL A 92 SHEET 1 AA213 MET A 60 THR A 65 0 SHEET 2 AA213 ASP A 47 HIS A 53 -1 N PHE A 48 O PHE A 64 SHEET 3 AA213 VAL A 38 ASP A 44 -1 N GLU A 40 O SER A 51 SHEET 4 AA213 GLY A 5 LYS A 13 -1 N PHE A 7 O THR A 39 SHEET 5 AA213 HIS B 58 THR B 65 -1 O LYS B 63 N GLU A 10 SHEET 6 AA213 ASP B 47 TYR B 54 -1 N TYR B 54 O HIS B 58 SHEET 7 AA213 VAL B 38 ASP B 44 -1 N VAL B 38 O HIS B 53 SHEET 8 AA213 GLY B 5 LYS B 13 -1 N PHE B 7 O THR B 39 SHEET 9 AA213 VAL B 118 ARG B 126 -1 O GLU B 121 N LYS B 13 SHEET 10 AA213 LYS B 108 ILE B 115 -1 N GLU B 111 O ARG B 122 SHEET 11 AA213 TYR B 98 ILE B 104 -1 N GLU B 103 O VAL B 110 SHEET 12 AA213 LYS B 90 PHE B 95 -1 N PHE B 95 O TYR B 98 SHEET 13 AA213 GLN B 85 GLU B 87 -1 N GLU B 87 O LYS B 90 SHEET 1 AA3 2 GLU A 69 GLN A 73 0 SHEET 2 AA3 2 THR A 79 THR A 83 -1 O ALA A 82 N SER A 70 SHEET 1 AA4 2 GLU B 69 GLN B 73 0 SHEET 2 AA4 2 THR B 79 THR B 83 -1 O PHE B 80 N ILE B 72 SHEET 1 AA5 9 THR C 59 THR C 65 0 SHEET 2 AA5 9 ASP C 47 HIS C 53 -1 N TRP C 50 O ASN C 62 SHEET 3 AA5 9 VAL C 38 ASP C 44 -1 N VAL C 38 O HIS C 53 SHEET 4 AA5 9 GLY C 5 LYS C 13 -1 N PHE C 7 O THR C 39 SHEET 5 AA5 9 VAL C 118 ARG C 126 -1 O LYS C 125 N GLU C 8 SHEET 6 AA5 9 LYS C 108 ILE C 115 -1 N SER C 113 O TYR C 120 SHEET 7 AA5 9 TYR C 98 ILE C 104 -1 N GLU C 103 O VAL C 110 SHEET 8 AA5 9 LYS C 90 PHE C 95 -1 N LEU C 91 O SER C 102 SHEET 9 AA5 9 GLN C 85 GLU C 87 -1 N GLN C 85 O VAL C 92 SHEET 1 AA6 2 SER C 70 ASN C 71 0 SHEET 2 AA6 2 LYS C 81 ALA C 82 -1 O ALA C 82 N SER C 70 SITE 1 AC1 2 GLN A 100 SER A 102 SITE 1 AC2 11 TYR B 15 TRP B 50 GLN B 52 ILE B 72 SITE 2 AC2 11 LEU B 91 GLN B 100 SER B 102 ARG B 122 SITE 3 AC2 11 HOH B1103 HOH B1108 HOH B1116 SITE 1 AC3 2 LEU B 22 LYS B 78 CRYST1 46.860 64.720 59.330 90.00 94.02 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021340 0.000000 0.001500 0.00000 SCALE2 0.000000 0.015451 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016896 0.00000 MASTER 357 0 3 6 37 0 5 6 0 0 0 30 END